These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23775366)

  • 1. Cost-effectiveness of laparoscopic fundoplication versus continued medical management for the treatment of gastro-oesophageal reflux disease based on long-term follow-up of the REFLUX trial.
    Faria R; Bojke L; Epstein D; Corbacho B; Sculpher M;
    Br J Surg; 2013 Aug; 100(9):1205-13. PubMed ID: 23775366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
    Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
    Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial).
    Grant AM; Boachie C; Cotton SC; Faria R; Bojke L; Epstein DM; Ramsay CR; Corbacho B; Sculpher M; Krukowski ZH; Heading RC; Campbell MK;
    Health Technol Assess; 2013 Jun; 17(22):1-167. PubMed ID: 23742987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the cost effectiveness of pharmacotherapy or surgery (laparoscopic fundoplication) in the treatment of GORD.
    Bojke L; Hornby E; Sculpher M;
    Pharmacoeconomics; 2007; 25(10):829-41. PubMed ID: 17887805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study.
    Epstein D; Bojke L; Sculpher MJ;
    BMJ; 2009 Jul; 339():b2576. PubMed ID: 19654097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults.
    Garg SK; Gurusamy KS
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD003243. PubMed ID: 26544951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of the RefluxStop device for management of refractory gastroesophageal reflux disease in Switzerland.
    Harper S; Kartha M; Mealing S; Borbély YM; Zehetner J
    J Med Econ; 2024; 27(1):805-815. PubMed ID: 38820006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term cost effectiveness and long-term cost analysis comparing laparoscopic Nissen fundoplication with proton-pump inhibitor maintenance for gastro-oesophageal reflux disease.
    Cookson R; Flood C; Koo B; Mahon D; Rhodes M
    Br J Surg; 2005 Jun; 92(6):700-6. PubMed ID: 15852426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX).
    Grant AM; Cotton SC; Boachie C; Ramsay CR; Krukowski ZH; Heading RC; Campbell MK;
    BMJ; 2013 Apr; 346():f1908. PubMed ID: 23599318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults.
    Wileman SM; McCann S; Grant AM; Krukowski ZH; Bruce J
    Cochrane Database Syst Rev; 2010 Mar; (3):CD003243. PubMed ID: 20238321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial.
    Grant AM; Wileman SM; Ramsay CR; Mowat NA; Krukowski ZH; Heading RC; Thursz MR; Campbell MK;
    BMJ; 2008 Dec; 337():a2664. PubMed ID: 19074946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluation.
    Goeree R; Hopkins R; Marshall JK; Armstrong D; Ungar WJ; Goldsmith C; Allen C; Anvari M
    Value Health; 2011; 14(2):263-73. PubMed ID: 21402295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of a novel, non-active implantable device as a treatment for refractory gastro-esophageal reflux disease.
    Harper S; Grodzicki L; Mealing S; Gemmill L; Goldsmith PJ; Ahmed AR
    J Med Econ; 2023; 26(1):603-613. PubMed ID: 37042668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of proton pump inhibitors versus laparoscopic Nissen fundoplication for patients with gastroesophageal reflux disease: a systematic review of the literature.
    Thijssen AS; Broeders IA; de Wit GA; Draaisma WA
    Surg Endosc; 2011 Oct; 25(10):3127-34. PubMed ID: 21487859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis.
    Comay D; Adam V; da Silveira EB; Kennedy W; Mayrand S; Barkun AN
    Can J Gastroenterol; 2008 Jun; 22(6):552-8. PubMed ID: 18560633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term symptom control of gastro-oesophageal reflux disease 12 years after laparoscopic Nissen or 180° anterior partial fundoplication in a randomized clinical trial.
    Roks DJ; Broeders JA; Baigrie RJ
    Br J Surg; 2017 Jun; 104(7):852-856. PubMed ID: 28158901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome is worse after laparoscopic than after conventional Nissen fundoplication.
    Franzén T; Anderberg B; Wirén M; Johansson KE
    Scand J Gastroenterol; 2005 Nov; 40(11):1261-8. PubMed ID: 16334434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trial of 270° posterior versus 180° anterior partial laparoscopic fundoplication for gastro-oesophageal reflux disease.
    Roks DJ; Koetje JH; Oor JE; Broeders JA; Nieuwenhuijs VB; Hazebroek EJ
    Br J Surg; 2017 Jun; 104(7):843-851. PubMed ID: 28295217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease.
    Funk LM; Zhang JY; Drosdeck JM; Melvin WS; Walker JP; Perry KA
    Surgery; 2015 Jan; 157(1):126-36. PubMed ID: 25262216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of surgical payer costs and implication on the healthcare expenses between laparoscopic magnetic sphincter augmentation (MSA) and laparoscopic Nissen fundoplication (LNF) in a large healthcare system.
    Ayazi S; Zaidi AH; Zheng P; Chovanec K; Chowdhury N; Salvitti M; Newhams K; Levy J; Hoppo T; Jobe BA
    Surg Endosc; 2020 May; 34(5):2279-2286. PubMed ID: 31376004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.